AzTrials
AzTrials

InfertilityNCT06979063

Health Education for Women With Suspeced Infertility Waiting for Specialized Care

A study testing Remote Infertility Education and Counseling in people with Infertility and Health Education, run by Hospital de Clinicas de Porto Alegre at 1 site in Brazil.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Introduction: Infertility is defined as a couple's inability to achieve pregnancy after 12 months or more of regular unprotected intercourse. In Brazil, it affects around eight million people. Read more about this study

Who is it for?
Ages 18 to 34 years, women only
Conditions the study is for
Infertility, Health Education, Telemedicine
What is being tested?
Remote Infertility Education and Counseling
Could I receive a placebo?
No, everyone receives an active treatment
How many people
206 participants
Where
1 siteBrazil
Study dates
Jun 2025to 31 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 34 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Individuals referred to specialized infertility care in Porto Alegre.
  • Age up to 33 years and 11 months.

Who cannot join

  • Lack of access to the internet or telephone.
  • Prior specialized infertility treatment in the private healthcare system.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Michele Strelow Moreira contact

+5551992607430

mstrelowmoreira@gmail.com

Helena von Eye Corleta contact

51999862749

hcorleta@hcpa.edu.br

Brazil1 site
  • Hospital de Clínicas de Porto Alegre (HCPA)

    Porto Alegre, Rio Grande do Sul, 90035-903

Other trials in Brazil

About this study

Official title: Impact of Regulation Strategies and Health Education for Managing Infertility in Primary Health Care in Rio Grande do Sul

Introduction: Infertility is defined as a couple's inability to achieve pregnancy after 12 months or more of regular unprotected intercourse. In Brazil, it affects around eight million people. While health services provide resources for contraception, little attention is given to supporting conception and preserving fertility.

Objective: To evaluate the effectiveness of a remote educational and counseling intervention on infertility.

Read more

Method: Open-label randomized clinical trial. Couples referred for infertility will be identified in the electronic referral system. For inclusion, the woman of the couple must be 34 years old or less, no previous in-vitro fertilization attempts, and have access to telephone or internet. The control group will follow standard care, awaiting in-person consultation. The intervention group will also wait for in-person evaluation but receive additional education and counseling via video call.

The primary outcome is the proportion of correct referrals according to local protocols. A total of 206 participants will be included to detect a difference between success rates of 50% and 30%, with 80% power and a 5% significance level.

Being tested
Remote Infertility Education and Counseling, Standard Care Arm
Medical subject headings
Infertility, Health Education

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Remote Infertility Education and CounselingOther

    Patients receive video call counseling covering infertility investigation, non-pharmacological fertility enhancement strategies, and healthcare navigation guidance.

    Health professionals review patient records and request missing infertility-related exams according to local protocol.

    Additional follow-ups occur approximately every 30 days to assist with pending investigations.

    If significant findings arise, patients will receive an explanation and assistance in scheduling primary care consultations.

  • Standard Care ArmOther

    Referrals from patients will be avaluated following local protocols in the electronic referral system. Incomplete data will be requested through this system. There will be no direct contact with patients.

Study groups in NCT06979063
Study groupRoleWhat they receive
Standard careActive comparatorWait for specialized infertility consultation, following the usual health system process.
Receives: Other: Standard Care Arm
intervention groupExperimentalRemote counseling and education about infertility and healthcare system navigation.
Receives: Other: Remote Infertility Education and Counseling; Other: Standard Care Arm

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Correct referral

    Proportion of participants correctly referred to specialized care according to local protocols.

    Measured: Six months after randomization

Secondary outcomes (4)
  1. Proportion of patients with conception plan achieved.

    Patient-reported conception plan will be evaluated by interview to assess whether pregnancy was achieved or it was opted to forgo the plan.

    Measured: Six months after randomization

  2. FertiQoL

    Change in Quality of Life as Measured by the Fertility Quality of Life (FertiQoL) Questionnaire. The FertiQoL is a validated instrument that measures quality of life in individuals experiencing fertility problems. Scores range from 0 to 100, where higher scores indicate better quality of life.

    Measured: Six months after randomization

  3. Time to regulation decision

    Time in days between the referral and final decision for the referral

    Measured: Six months after randomization

  4. Time for in-person consulting

    Time in days between the referral and in-person consult.

    Measured: Six months after randomization

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 May 2025
  2. Study startJun 2025 (estimated)
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is an open-label, superiority, randomized controlled trial with two parallel groups. Participants will be assigned to either a control group, which follows standard care, or an intervention group, which receives remote counseling and education about infertility and healthcare system navigation.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
206 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06979063
Sponsor's protocol ID
2022-0588
Status last verified
May 2025
First submitted
24 Apr 2025
Last updated
18 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Remote Infertility Education and Counseling in people with Infertility and Health Education, run by Hospital de Clinicas de Porto Alegre at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 18 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Michele Strelow Moreira (+5551992607430, mstrelowmoreira@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Correct referral (time frame: Six months after randomization). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in